tirzepatide plus compounding pharmacy Compounded GLP-1/GIP (Tirzepatide) sustainable wellness goals. Compounded Tirzepatide Weight Management Program
Description
It usually improves as your body adjusts to the medication
The primary side effects documented in clinical trials are gastrointestinal, including nausea, diarrhea, vomiting, and constipation
The FDA gives guidance through the federal law, like Section 503A
If dizziness continues despite these adjustments, consult your healthcare provider
Tirzepatide (sold as Mounjaro and Zepbound) is FDA approved and available now, while Retatrutide remains in Phase 3 trials with expected approval sometime between 2026 and 2027
Compounded tirzepatide shelf life This is where things get more complicated
